On the public citation graph
Safety and Efficacy of Single HDIT101 Infusion Versus Episodic Valacyclovir Standard-of-Care in Patients with Chronic Recurrent Anogenital Herpes Simplex Virus 2 (HSV-2) Infection: A Multicentre, Parallel-Group Design, Randomised, Double-Blind, Double-Dummy Phase 2 Trial
0 signed · 20 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.1996.00440140169018openalex-extracted
A Large-Scale, Placebo-Controlled, Dose-Ranging Trial of Peroral Valaciclovir for Episodic Treatment of Recurrent Herpes Genitalis
inferredcites →https://doi.org/10.1001/jama.2016.18189openalex-extracted
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences
inferredcites →https://doi.org/10.1023/a:1008857426633openalex-extracted
The international development of the RGHQoL: a quality of life measure for recurrent genital herpes
inferredcites →https://doi.org/10.1038/ijos.2016.3openalex-extracted
New strategies against drug resistance to herpes simplex virus
inferredcites →https://doi.org/10.1073/pnas.1220019110openalex-extracted
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody
inferredcites →https://doi.org/10.1086/339326openalex-extracted
Valacyclovir for Episodic Treatment of Genital Herpes: A Shorter 3‐Day Treatment Course Compared with 5‐Day Treatment
inferredcites →https://doi.org/10.1093/cid/ciy562openalex-extracted
The Epidemiology of Herpes Simplex Virus Type 1 in Asia: Systematic Review, Meta-analyses, and Meta-regressions
inferredcites →https://doi.org/10.1093/infdis/jiy415openalex-extracted
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial
inferredcites →https://doi.org/10.1111/cts.13365openalex-extracted
First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers
inferredcites →https://doi.org/10.1111/j.1524-4733.2008.00424.xopenalex-extracted
The Development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire
inferredcites →https://doi.org/10.1128/jvi.01924-10openalex-extracted
Impact of Valency of a Glycoprotein B-Specific Monoclonal Antibody on Neutralization of Herpes Simplex Virus
inferredcites →https://doi.org/10.1172/jci142088openalex-extracted
B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin
inferredcites →https://doi.org/10.1177/1359105310367528openalex-extracted
The Psychological Impact of Genital Herpes Stigma
inferredcites →https://doi.org/10.1186/s12916-019-1285-xopenalex-extracted
Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions
inferredcites →https://doi.org/10.3389/fimmu.2019.00332openalex-extracted
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
inferredcites →https://doi.org/10.3389/fimmu.2022.867962openalex-extracted
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens
inferredcites →https://doi.org/10.3389/fimmu.2023.1143870openalex-extracted
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study
inferredcites →https://doi.org/10.4049/jimmunol.1800471openalex-extracted
A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection
inferredcites →https://doi.org/10.4161/mabs.2.3.11641openalex-extracted
The immunogenicity of humanized and fully human antibodies
inferredcites →https://doi.org/10.1001/archinte.156.15.1729openalex-snapshot
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.